These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 21416762)

  • 21. Immunising the population. Are we succeeding?
    Carnie J
    Aust Fam Physician; 1997 Aug; 26(8):925-31. PubMed ID: 9267057
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Surveillance of adverse events following immunisation for children aged less than 7 years, 1 January to 30 June 2004.
    Lawrence G; Boyd I
    Commun Dis Intell Q Rep; 2004; 28(4):490-2. PubMed ID: 15747426
    [No Abstract]   [Full Text] [Related]  

  • 23. Vaccine preventable diseases and vaccination coverage in Australia 2001 to 2002.
    Brotherton J; McIntyre P; Puech M; Wang H; Gidding H; Hull B; Lawrence G; MacIntyre R; Wood N; Armstrong D
    Commun Dis Intell Q Rep; 2004 Dec; 28 Suppl 2():vii-S116. PubMed ID: 15732752
    [No Abstract]   [Full Text] [Related]  

  • 24. Australia's notifiable diseases status, 2002: Annual report of the National Notifiable Diseases Surveillance System.
    Yohannes K; Roche P; Blumer C; Spencer J; Milton A; Bunn C; Gidding H; Kirk M; Della-Porta T
    Commun Dis Intell Q Rep; 2004; 28(1):6-68. PubMed ID: 15072156
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vaccine preventable diseases and vaccination coverage in Aboriginal and Torres Strait Islander people, Australia 2003 to 2006.
    Menzies R; Turnour C; Chiu C; McIntyre P
    Commun Dis Intell Q Rep; 2008 Jun; 32 Suppl():S2-67. PubMed ID: 18711998
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Communicable enteric disease surveillance, New South Wales, 2000-2002.
    Neville L; McAnulty J
    N S W Public Health Bull; 2004; 15(1-2):18-23. PubMed ID: 15064780
    [No Abstract]   [Full Text] [Related]  

  • 27. Supplementary report: surveillance of adverse events following immunisation among children aged less than 7 years in Australia, 1 January to 30 June 2007.
    Lawrence GL; Aratchige PE; Hill R
    Commun Dis Intell Q Rep; 2007 Dec; 31(4):379-82. PubMed ID: 18268878
    [No Abstract]   [Full Text] [Related]  

  • 28. Supplementary report: surveillance of adverse events following immunisation among children aged less than 7 years in Australia, 1 January to 30 June 2010.
    Mahajan D; Menzies R; Cook J; Macartney K; Mclntyre P
    Commun Dis Intell Q Rep; 2011 Mar; 35(1):21-8. PubMed ID: 21698980
    [No Abstract]   [Full Text] [Related]  

  • 29. Supplementary report: surveillance of adverse events following immunisation among children aged less than 7 years in Australia, 1 January to 30 June 2005.
    Lawrence G; Boyd I
    Commun Dis Intell Q Rep; 2005; 29(4):413-6. PubMed ID: 16465935
    [No Abstract]   [Full Text] [Related]  

  • 30. Surveillance of adverse events following immunisation: Australia, 2000-2002.
    Lawrence G; Menzies R; Burgess M; McIntyre P; Wood N; Boyd I; Purcell P; Isaacs D
    Commun Dis Intell Q Rep; 2003; 27(3):307-23. PubMed ID: 14510057
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Supplementary report: surveillance of adverse events following immunisation among children aged < 7 years in Australia, 1 January to 30 June 2006.
    Lawrence G; Boyd I
    Commun Dis Intell Q Rep; 2006; 30(4):438-42. PubMed ID: 17330385
    [No Abstract]   [Full Text] [Related]  

  • 32. Supplementary report: surveillance of adverse events following immunisation among children aged less than seven years in Australia, 1 January to 30 June 2012.
    Mahajan D; Cook J; Dey A; Macartney K; Menzies R
    Commun Dis Intell Q Rep; 2013 Jun; 37(2):E130-4. PubMed ID: 24168086
    [No Abstract]   [Full Text] [Related]  

  • 33. Notifications of vaccine preventable diseases in Australia. Quarterly report (January-March 2000).
    Gidding HF; Amin J; McIntyre PB
    Commun Dis Intell; 2000 Aug; 24(8):239-41. PubMed ID: 11022391
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Surveillance data in CDI.
    Commun Dis Intell; 1998 Jan; 22(1):4-8. PubMed ID: 9503743
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Supplementary report: surveillance of adverse events following immunisation among children aged less than seven years in Australia, 1 January to 30 June 2009.
    Mahajan D; Menzies R; Roomiani I; Lawrence G
    Commun Dis Intell Q Rep; 2010 Mar; 34(1):49-53. PubMed ID: 20521499
    [No Abstract]   [Full Text] [Related]  

  • 36. Communicable diseases surveillance.
    Commun Dis Intell; 1997 Jul; 21(15):208-15. PubMed ID: 9257482
    [TBL] [Abstract][Full Text] [Related]  

  • 37. National Centre for Immunisation Research and Surveillance of Vaccine Preventable Diseases.
    Commun Dis Intell Q Rep; 2004; 28(1):92-5. PubMed ID: 15072163
    [No Abstract]   [Full Text] [Related]  

  • 38. The Laboratory Virology and Serology Reporting Scheme, 1991 to 2000.
    Roche P; Halliday L; O'Brien E; Spencer J
    Commun Dis Intell Q Rep; 2002; 26(3):323-74. PubMed ID: 12416701
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunisation in general practice. Results from the Australian Morbidity and Treatment Survey, 1990-1991.
    Traynor V; Britt H; Bridges-Webb C; Sayer GP; Meza RA; Charles J
    Aust Fam Physician; 1996 Mar; 25(3):355-9. PubMed ID: 8867187
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Communicable Diseases Surveillance.
    Commun Dis Intell; 1998 Mar; 22(3):40-7. PubMed ID: 9557390
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.